Equillium (EQ) Current Leases (2021 - 2026)
Equillium's (EQ) quarterly Current Leases came in at $441000.0 in Q1 2026, up 202.05% year-on-year from $146000.0 in Q1 2025, and up 21.49% on a QoQ basis from $363000.0 in Q4 2025.
Equillium (EQ) Current Leases (2021 - 2026) Analysis & Trends
Equillium (EQ) has 6 years of Current Leases data on file, last reported at $441000.0 in Q1 2026.
- On a quarterly basis, Current Leases rose 202.05% year-over-year to $441000.0 in Q1 2026; TTM through Mar 2026 was $441000.0, a 202.05% increase from a year earlier, with the FY2025 full-year figure at $363000.0, up 84.26% from the prior year.
- Current Leases for Q1 2026 stood at $441000.0, up from $363000.0 in the prior quarter.
- Over the last five years, Current Leases for EQ reached as high as $441000.0 in Q1 2026 and fell as low as $146000.0 in Q1 2025.
- Historically, Current Leases has averaged $352235.3 across 5 years, with a median of $408000.0 in 2022.
- Across the five-year window, Current Leases tumbled 65.57% in 2025 and surged 202.05% in 2026, its largest moves.
- Year by year, Current Leases stood at $408000.0 in 2022, then gained by 7.84% to $440000.0 in 2023, then slumped by 55.23% to $197000.0 in 2024, then jumped by 84.26% to $363000.0 in 2025, then grew by 21.49% to $441000.0 in 2026.
- Per Business Quant data, the three most recent Current Leases figures were $441000.0 in Q1 2026, $363000.0 in Q4 2025, and $272000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - | 441,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 441,000.00 |
| Dec 31, 2025 | 363,000.00 |
| Sep 30, 2025 | 272,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Mar 31, 2025 | 146,000.00 |
| Dec 31, 2024 | 197,000.00 |
| Sep 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 350,000.00 |
| Mar 31, 2024 | 424,000.00 |
| Dec 31, 2023 | 440,000.00 |
| Sep 30, 2023 | 428,000.00 |
| Jun 30, 2023 | 416,000.00 |
| Mar 31, 2023 | 404,000.00 |
| Dec 31, 2022 | 408,000.00 |
| Sep 30, 2022 | 421,000.00 |
| Jun 30, 2022 | 434,000.00 |
| Mar 31, 2022 | 420,000.00 |
| Dec 31, 2021 | 376,000.00 |